FOXP2 and childhood apraxia of speech: Reduced functional dosage of FOXP2, caused by mutation or chromosomal rearrangements, leads to characteristic deficits in coordinating sequences of orofacial movements, impairing speech, producing a disorder known as developmental verbal dyspraxia (DVD) or childhood apraxia of speech (CAS) [18–22].